Publications by authors named "Thomas Carty"

Claim this Profile
C
Configurational stability for the Kuramoto-Sakaguchi model.
Jared C Bronski, Thomas Carty, Lee DeVille

Chaos· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure-activity relationships of triazolopyridine oxazole p38 inhibitors: identification of candidates for clinical development.
Kim F McClure, Michael A Letavic, Amit S Kalgutkar, Christopher A Gabel, Laurent Audoly, Thomas J Carty

Bioorg Med Chem Lett· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Theoretical and experimental design of atypical kinase inhibitors: application to p38 MAP kinase.
Kim F McClure, Yuriy A Abramov, Ellen R Laird, John T Barberia, Weiling Cai, Thomas J Carty

J Med Chem· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of 3-OH-3-methylpipecolic hydroxamates: potent orally active inhibitors of aggrecanase and MMP-13.
Mark C Noe, Vijayalakshmi Natarajan, Sheri L Snow, Lilli A Wolf-Gouveia, Peter G Mitchell, Thomas J Carty

Bioorg Med Chem Lett· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of 3,3-dimethyl-5-hydroxypipecolic hydroxamate-based inhibitors of aggrecanase and MMP-13.
Mark C Noe, Vijayalakshmi Natarajan, Sheri L Snow, Peter G Mitchell, Lori Lopresti-Morrow, Thomas J Carty

Bioorg Med Chem Lett· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Redirection of eicosanoid metabolism in mPGES-1-deficient macrophages.
Catherine E Trebino, James D Eskra, Timothy S Wachtmann, Jose R Perez, Thomas J Carty

J Biol Chem· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benzimidazolone p38 inhibitors.
Mark A Dombroski, Michael A Letavic, Kim F McClure, John T Barberia, Thomas J Carty

Bioorg Med Chem Lett· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and biological activity of piperazine-based dual MMP-13 and TNF-alpha converting enzyme inhibitors.
Michael A Letavic, John T Barberia, Thomas J Carty, Joel R Hardink, Jennifer Liras

Bioorg Med Chem Lett· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impaired inflammatory and pain responses in mice lacking an inducible prostaglandin E synthase.
Catherine E Trebino, Jeffrey L Stock, Colleen P Gibbons, Brian M Naiman, Timothy S Wachtmann, Thomas J Carty

Proc Natl Acad Sci U S A· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of IL-1beta-dependent prostaglandin E2 release by antisense microsomal prostaglandin E synthase 1 oligonucleotides in A549 cells.
Francis J Sweeney, Timothy S Wachtmann, James D Eskra, Kimberley A Verdries, Ralph H Lambalot, Thomas J Carty

Mol Cell Endocrinol· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of tumor necrosis factor-alpha converting enzyme (TACE) and metalloprotease inhibitor on amyloid precursor protein metabolism in human neurons.
Megan Blacker, Mark C Noe, Thomas J Carty, Cynthia G Goodyer, Andréa C LeBlanc

J Neurochem· December 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and biological activity of selective pipecolic acid-based TNF-alpha converting enzyme (TACE) inhibitors.
Michael A Letavic, Matt Z Axt, John T Barberia, Thomas J Carty, Dennis E Danley

Bioorg Med Chem Lett· May 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis